- Medical School - Indiana University School of Medicine (2011-2015)
- Internship - UT Southwestern Medical Center (2015-2016), Internal Medicine
- Residency - UT Southwestern Medical Center (2016-2018), Internal Medicine
- Fellowship - Duke University Medical Center (2019-2022), Hematology Oncology
Heather Wolfe, M.D.
- Internal Medicine - Hematology/Oncology
- Cancer Survivorship
- Chronic Lymphocytic Leukemia
New Patient Appointment Accepting Virtual Visits or 214-645-4673
Biography
Heather Wolfe, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in leukemia and lymphoma, and her clinical interests include cancer survivorship, chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma, and other indolent lymphomas.
Dr. Wolfe earned her medical degree at Indiana University, where she also earned a master’s degree in biology. She completed a residency in internal medicine at UT Southwestern, where she served as Chief Resident, then gained advanced training in hematology and oncology at Duke University, where she was Chief Fellow.
Certified by the American Board of Internal Medicine, Dr. Wolfe joined the UT Southwestern faculty in 2022.
She is the Director of CLL Survivorship at UT Southwestern.
Dr. Wolfe is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the Texas Medical Association.
Her research interests include cancer survivorship, quality-of-life improvement in patients with CLL and lymphoma, and novel therapies and patient-centered outcomes for lymphoma and leukemia. She has published several articles in peer-reviewed journals related to these topics.
In 2021, Dr. Wolfe was named Fellow of the Year by the North Carolina Oncology Association.
Personal Note
Outside of work, Dr. Wolfe enjoys traveling, cooking, gardening, and spending time with her family.
Education & Training
Professional Associations & Affiliations
- American Society of Clinical Oncology
- American Society of Hematology
- Texas Medical Association
Honors & Awards
- Fellow of the Year 2021, North Carolina Oncology Association
Books & Publications
-
Publications
-
The Use of Allogeneic Hematopoietic Stem Cell Transplantation in Primary Myelofibrosis.
Wolfe HR, Horwitz ME, Rein LAM, Journal of personalized medicine 2022 Apr 12 4 -
The Evolving Landscape of Frontline Therapy in Chronic Phase Chronic Myeloid Leukemia (CML).
Wolfe HR, Rein LAM, Current hematologic malignancy reports 2021 10 16 5 448-454 -
I Have Neutropenia-What Do I Need to Know?
Gupta A, Wolfe HR, West HJ JAMA oncology 2018 Aug -
Things We Do For No Reason: Neutropenic Diet.
Wolfe HR, Sadeghi N, Agrawal D, Johnson DH, Gupta A Journal of hospital medicine 2018 May -
Treatment of Immune Thrombocytopenia: A Teachable Moment.
Wolfe HR, Bhushan M, Choi SH JAMA internal medicine 2018 Mar 178 3 406-407 -
Evaluating Thrombocytopenia During Heparin Therapy.
Shen YM, Wolfe H, Barman S JAMA 2018 Feb 319 5 497-498 -
Unnecessary Staging Imaging in Early-Stage Breast Cancer: A Teachable Moment.
Wolfe HR, Gupta A, Sadeghi N JAMA internal medicine 2017 Oct 177 10 1516-1517
-
The Use of Allogeneic Hematopoietic Stem Cell Transplantation in Primary Myelofibrosis.
Research
- Cancer survivorship
- Novel therapies/drug combinations
- Patient-centered outcomes
- Quality-of-life improvements in patients with chronic lymphocytic leukemia (CLL) and lymphoma
Clinical Focus
- Cancer Survivorship
- Chronic Lymphocytic Leukemia
- Hematologic Malignancies
- Hematology and Oncology
- Indolent Lymphomas
- Small Lymphocytic Lymphoma
Results: 1 Locations
Blood Cancers/Transplant and Cellular Therapies Clinic
at Cancer Care Outpatient Building 6202 Harry Hines Blvd., 6th FloorDallas, Texas 75235 (214) 645-4673 Directions to Blood Cancers/Transplant and Cellular Therapies Clinic Parking Info for Blood Cancers/Transplant and Cellular Therapies Clinic
New Patient Appointment Accepting Virtual Visits or 214-645-4673